Safa'a Al-Rais
Operationeel Directeur bij Resilience Biotechnologies, Inc.
Profiel
Safa'a Al-Rais is currently the Chief Operating Officer at Resilience Biotechnologies, Inc. Prior to this, he worked at Therapure Biopharma, Inc. from 2009 to 2020 as the Vice President-Operations.
Actieve functies van Safa'a Al-Rais
| Bedrijven | Functie | Begin |
|---|---|---|
Resilience Biotechnologies, Inc.
 Resilience Biotechnologies, Inc. BiotechnologyHealth Technology Part of National Resilience, Inc., Resilience Biotechnologies, Inc. operates as a Canadian biotechnology company. The CEO of the company is Rahul Singhvi. | Operationeel Directeur | - |
Eerdere bekende functies van Safa'a Al-Rais
| Bedrijven | Functie | Einde |
|---|---|---|
Therapure Biopharma, Inc.
 Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | Operationeel Directeur | 01-10-2020 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | Health Technology |
Resilience Biotechnologies, Inc.
Resilience Biotechnologies, Inc. BiotechnologyHealth Technology Part of National Resilience, Inc., Resilience Biotechnologies, Inc. operates as a Canadian biotechnology company. The CEO of the company is Rahul Singhvi. | Health Technology |
